Aurora Cannabis Inc. (ACB)

The year is a more than a month old, but Aurora Cannabis (ACB -2.87%) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year began --...

Aurora Cannabis (ACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Last week, Aurora Cannabis reported blowout Q3/FY2025 results with sales, gross margins, profitability, and free cash flow reaching new all-time highs. As a leader in the medical cannabis space, the c...

The patience of some marijuana stock investors is still being tested. The public sector for cannabis is a victim of uncertainty and fear in more grey areas. What this means is in the USA there is no f...

Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins and generating solid cash flows. The company reported FQ3 revenues of C$88 million and a significant im...

Aurora Cannabis Inc. (NASDAQ:ACB ) Q3 2025 Earnings Conference Call February 5, 2025 8:00 AM ET Company Participants Kevin Niland - Director of Strategic Finance and Investor Relations Miguel Martin -...

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to loss of $0.20 per share a year ago.

Canada-based global medical cannabis company Aurora Cannabis Inc ACB reported a third-quarter fiscal 2025 net revenue of CA$88.2 million, compared to CA$64.4 million a year ago.

The cannabis industry remains a rapidly expanding sector, with significant growth expected in the coming years. In the United States alone, legal cannabis sales surpassed $25 billion in 2021 and are p...

The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by ...